About this trial
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
fatty liver (non alcoholic form)
both sexes included
obese subjects (class I)
Disqualifiers
cardiac insult
respiratory insult
renal insult
lower limb insult
Trial design
Parallel
Treatments tested in this trial
honey intake and lifestyle changes
BehavioralTwenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive natural unprocessed honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
lifestyle changes
BehavioralTwenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Treatment groups
Trial outcomes
Primary outcomes
High density lipoprotein
it will be measured in serum
Secondary outcomes
triglycerides
it will be measured in serum
cholesterol
it will be measured in serum
low density lipoprotein
it will be measured in serum
alanine transamianse
it will be measured in serum
Sponsors and contacts
Click on the lead sponsor to view all of their trials.